Ascendis Pharma (ASND) PT Lowered to $113 at BofA Securities
Tweet
Share
E-mailGet Alerts ASND Hot Sheet
Price: $260.25 -1.06%
Rating Summary:
23 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
23 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
BofA Securities analyst Tazeen Ahmad lowered the price target on Ascendis Pharma (NASDAQ: ASND) to $113.00 (from $115.00) while maintaining a Buy rating.
You May Also Be Interested In
- Ascendis Pharma (ASND) PT Raised to $312 at Oppenheimer
- GDS Holdings (GDS) PT Lowered to $51 at Raymond James
- Medtronic, Inc. (MDT) PT Raised to $100 at BTIG
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
